Navigation Links
AACR colorectal cancer conference to focus on screening, new treatments

PHILADELPHIA The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

Colorectal cancer is the third leading cause of cancer in men and women. While screening has brought mortality rates down, much work remains to be done.

"Colorectal cancer is still one of the deadliest cancers, and our current screening methods are not yet always efficient or complete," said Anil Rustgi, M.D., chief of gastroenterology, T. Grier Miller Professor of Medicine and Genetics, and American Cancer Society Professor at the University of Pennsylvania School of Medicine and a program chairperson of the AACR special conference.

Rustgi will host a press conference on Thursday, Oct. 28 at 1:00 p.m. ET in the Adams Room on the third floor of the Loews Hotel in Philadelphia. The press conference will feature the following new research:

  • Telomere Length Affects Colorectal Cancer Risk
  • New Colorectal Screening Test Measures DNA Methylation
  • FAK Inhibitor Effectively Blocked Colon Cancer Cell Growth and Viability
  • Jekyll-Hyde MicroRNA Binding Variant Linked to Improved Outcome in Early-stage Colorectal Cancer

Reporters who cannot attend in person can participate using the following information:

Dial-in (U.S. and Canada): (888) 282-7404
Dial-in (International): (706) 679-5207
Access Code: 18304706

The American Association for Cancer Research Communications Department has also identified the following research as newsworthy:

  • Researchers Build Colony of Colon Cancer Stem Cells to Test New Approach to Therapy
  • Small-molecule Inhibitors Effectively Targeted Active Colon Cancer Enzyme


Contact: Jeremy Moore
American Association for Cancer Research

Page: 1

Related biology news :

1. Hormone therapy associated with reduced colorectal cancer risk
2. Rural areas able to increase screening capacity for colorectal cancer
3. Study finds colorectal cancer rates increasing worldwide
4. Colorectal cancer
5. Cigarette smoking increases colorectal cancer risk
6. Breast cancer treatment resistance linked to signaling pathway
7. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
8. The dietary supplement genistein can undermine breast cancer treatment
9. Saliva proteins could help detection of oral cancer
10. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
11. Breakthrough optical technology to assess colon cancer risk, accuracy
Post Your Comments:
(Date:11/26/2015)... -- Research and Markets ( ) has announced ... Technology and Patent Infringement Risk Analysis" report to ... --> Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:11/18/2015)... 2015  As new scientific discoveries deepen our understanding ... healthcare providers face challenges in better using that knowledge ... addition, as more children continue to survive pediatric cancer, ... old age. John M. Maris, M.D ., ... Philadelphia (CHOP) . --> John M. ...
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... 30, 2015  Champions Oncology, Inc. (CSBR), engaged in ... personalize the development and use of oncology drugs, today ... will be presenting at the LD MICRO Investor Conference ... Time (PST).  The conference, held at the Luxe Sunset ... , will feature 200 small/micro-cap companies and is ...
(Date:11/30/2015)... JACKSONVILLE, Florida , November 30, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, today announced it will be presenting ... Event on December 1, 2015 at 2.30 PM PT. ... member and Strategic Advisor will be giving the presentation ...
(Date:11/30/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a commercial-stage specialty healthcare ... at two upcoming investor conferences. Aytu is scheduled to ... to be held December 3, 2015, and at LD ... 2 nd & 3 rd , 2015 in ... via webcast. Josh Disbrow , Chief Executive ...
(Date:11/30/2015)... Florida and MAGDEBURG, Germany , ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... 3rd European Congress of NeuroRehabilitation (ECNR) in ... --> NovaVision, a wholly owned subsidiary of Vycor ... European version of its Internet-delivered NovaVision Therapy Suite at the ...
Breaking Biology Technology: